Specifications
- Purity
- ≥98% (NMR)
- Appearance
- White powder
- Identity
- 1H-NMR
Properties
- Melting Point
- 165-167 °C
Documentation
- Safety Data Sheet (SDS)
- CDX H0080 MSDS.pdf
Category: Quorum Sensing
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
Neuroprotective compound in experimental models of neurodegenerative diseases. Shown to be oxidized as an energetic substrate in the brain during starvation. May inhibit brain glucose oxidation, which may account for the suppression of hepatic glucose production observed after administration of ketone bodies in humans.
Synonyms | Sodium 3-hydroxybutyrate, β-Hydroxybutyrate sodium salt |
---|---|
Purity | ≥98% (NMR) |
Appearance | White powder |
CAS-Number | 150-83-4 |
Molecular Formula | C4H7NaO3 |
Molecular Weight | 126.1 |
Identity | 1H-NMR |
Melting Point | 165-167 °C |
Smiles | [Na+].CC(O)CC([O-])=O |
InChi Key | NBPUSGBJDWCHKC-UHFFFAOYSA-M |
Shipping | AMBIENT |
Short Term Storage | +4°C |
Long Term Storage | -20°C |
Handling Advice | Protect from light and moisture. |
Use / Stability | Stable for at least 2 years after receipt when stored at -20°C. |
Transportation | Not dangerous goods |
References | (1) P. Bjorntorp & T. Schersten: Amer. J. Physiol. 212, 683 (1967), (2) E. Balasse & H.A. Ooms: Diabetol. 4, 133 (1968), (3) N. Hotta, et al.: Can. J. Physiol. Pharmacol. 49, 87 (1971), (4) R. Chiolero, et al.: Am. J. Clin. Nutr. 58, 608 (1993), (5) B. Plecko, et al.: Ped. Res. 52, 301 (2002), (6) S. Thaler, et al.: Graefes Arch. Clin. Exp. Ophthalmol. 248, 1729 (2010) |
InChi | InChI=1S/C4H8O3.Na/c1-3(5)2-4(6)7 |
Quantity | 1 g, 10 g, Bulk |